I curricula vengono aggiornati a seguito dell’invio delle modifiche da parte del dipendente.
2017 – Certificazione IOTA (ecografia massa annessiale)
2016-2017 – ESGO-ENYGO Masterclass (patologia cervicale e oncologia ginecologica)
2017 – Specializzazione in Ginecologia e Ostetricia, Università di Torino – 70/70 con lode
2010 – Abilitazione alla professione di Medico Chirurgo – Ordine dei Medici di Cuneo n. 4231
2009 – Laurea Magistrale in Medicina e Chirurgia, Università di Torino – 110/110 con lode
2003 – Maturità Scientifica PNI, Liceo Giolitti Gandino (Bra) – 100/100
Gen 2025 – oggiDirigente Medico I Livello – S.C. Oncologia, ASL CN2Ospedale Michele e Pietro Ferrero, Verduno e Attività libero-professionale extramoenia presso studi medici
Gen 2021 – Dic 2024Dirigente Medico I Livello – Ginecologia e Ostetricia, ASL CN2Ospedale Michele e Pietro Ferrero, Verduno e Attività libero-professionale extramoenia presso studi medici
Giu 2020 – Gen 2021 Ginecologa libera professionista presso Centro Medico San Giovanni (Canale), SA.LU.COM (Savigliano), Riabilita (Bra)
Lug 2018 – Mag 2020 Ginecologa libera professionista presso Centro Medico Santagostino, Milano
Lug 2017 – Giu 2018 Collaboratore Professionale – IRCCS Istituto Tumori MilanoUnità di Terapia Medica Ginecologica OncologicaSub-investigator in numerosi studi clinici internazionali
Mar 2017 – Giu 2017 Medico frequentatore volontario – IRCCS Istituto Tumori MilanoReparto di Chirurgia Ginecologica
Lug 2011 – Gen 2017 Medico in formazione specialistica – Ospedale Mauriziano Umberto I, Torino
Italiano – madre lingua Inglese – buono (certificazione PET)
2023
Serous endometrial cancer confined to a polyp with malignant pleural effusion. Mauro J, Filipello F, Tripodi E, Di Guardia G, Buda A. Int J Gynecol Cancer. 2023 Nov 6;33(11):1812-1818. doi: 10.1136/ijgc-2023-004942.
2022
Neoadjuvant Chemotherapy Prior Fertility-Sparing Surgery in Women with FIGO 2018 Stage IB2 Cervical Cancer: A Systematic Review Buda A, Borghese M, Puppo A, Perotto S, Novelli A, Borghi C, Olearo E,
Tripodi E, Surace A, Bar E, Scambia G, Fanfani F.. Cancers (Basel). 2022 Feb 4;14(3):797. Doi: 10.3390/cancers14030797. PMID: 35159063; PMCID: PMC8833789.
2021
Lorusso, D., Maltese, G., Sabatucci, I., Tripodi, E. (2021). Ovarian Cancer, Early Primary Disease. In: Russo, A., Peeters, M., Incorvaia, L., Rolfo, C. (eds) Practical Medical Oncology Textbook. UNIPA Springer Series. Springer, Cham. https://doi.org/10.1007/978-3-030-56051-5_51
2019
– Surgery on breast cancer in pregnancy Liberale V, Tripodi E, Ottino L, Biglia N. Transl Cancer Res. 2019 Oct;8 (Suppl 5): S493-S502. doi: 10.21037/tcr.2019.07.16. PMID: 35117127; PMCID: PMC8797300.
– Treatment of recurrent ovarian cancer with pegylated liposomal doxorubicin: a reappraisal and critical analysis. Lorusso D, Sabatucci I, Maltese G, Lepori S, Tripodi E, Bogani G, Raspagliesi F. Tumori. 2019 Mar 28:300891619839308. doi: 10.1177/0300891619839308.
– Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study. Tripodi E, Cormio G, De Giorgi U, Valabrega G, Rubino D, Lepori S, Maltese
G, Sabatucci I, Lorusso D. Int J Gynecol Cancer. 2019 Jan;29(1):153-157. doi: 10.1136/ijgc-2018-000034.—– Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study. Maltese G, Lepori S, Sabatucci I, Tripodi E, Lorusso D. Int J Gynecol Cancer. 2019 Jan 13. pii: ijgc-2018-000085. doi: 10.1136/ijgc- 2018-000085.
– Can Vulnerable Elders Survey-13 predict the impact of frailty on chemotherapy in elderly patients with gynaecological malignancies? Ferrero A, Villa M, Tripodi E, Fuso L, Menato G. Medicine (Baltimore). 2018 Sep;97(39):e12298. doi: 10.1097/MD.0000000000012298
2018
Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?
Lorusso D, Martinelli F, Maltese G, Fontanella C, Sabatucci I, Ditto A, Signorelli M, Bogani G, Lepori S, Tripodi E, Pappalardi B, Scaffa C, Cerrotta A, Rapagliesi F. Oncology. 2018;95(4):239-245. doi: 10.1159/000489886. Epub 2018 Jun 19
– Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy. Lorusso D, Tripodi E, Maltese G, Lepori S, Sabatucci I, Bogani G, Raspagliesi F. Drug Des Devel Ther. 2018 May 29;12:1501-1509. doi: 10.2147/DDDT.S124447. eCollection 2018. Review.
– Rucaparib: a new treatment option for ovarian cancer. Sabatucci I, Maltese G, Lepori S, Tripodi E, Bogani G, Lorusso D. Expert Opin Pharmacother. 2018 May;19(7):765-771. doi:10.1080/14656566.2018.1464557. Epub 2018 Apr 19.
2017
– Ovarian Cancer in Elderly Patients: Patterns of Care and Treatment Outcomes According to Age and Modified Frailty Index. Ferrero A, Fuso L, Tripodi E, Tana R, Daniele A, Zanfagnin V, Perotto S, Gadducci A. Int J Gynecol Cancer. 2017 Nov;27(9):1863-1871. doi: 10.1097/IGC.0000000000001097.
– The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer. Lorusso D, Fontanella C, Maltese G, Lepori S, Tripodi E, Bogani G, Raspagliesi F. Expert Opin Drug Saf. 2017 Jun;16(6):687-696. doi: 10.1080/14740338.2017.1325871. Epub 2017 May 18 2016
– Is Ovarian Cancer Being Managed According to Clinical Guidelines? Evidence From a Population-Based Clinical Audit. Sobrero S, Pagano E, Piovano E, Bono L, Ceccarelli M, Ferrero A, Macchi C, Mistrangelo M, Patriarca S, Tripodi E, Zanetti R, Bertetto O, Ciccone G, Zola P. Int J Gynecol Cancer. 2016 Nov;26(9):1615-1623.
– ESGO TEXT BOOK THIRD EDITION Chapter 161. Surgical Oncological Care of Elderly Patients Pauline Wimberger, MD, PhD, Annamaria Ferrero, MD, PhD Elisa Tripodi, MD Chapter 162. Medical Oncological Care of Elderly Patients Annamaria Ferrero, MD, PhD, Pauline Wimberger, MD, PhD Elisa Tripodi, MD
Abstract from 16th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2016)
-QUALITY INDICATORS (QIs) IN ADVANCED OVARIAN CANCER MANAGEMENT E.Tripodi, L. Fuso, D. Attianese, M. Villa, V. Zanfagnin, G. Menato, A.Ferrero
-IMPACT OF FRAILTY ON SURGICAL AND MEDICAL TREATMENT IN ELDERLY PATIENTS WITH GYNECOLOGICAL MALIGNANCIES E. Tripodi, A. Ferrero, M. Villa, L. Fuso, G. Menato
2015
-Tripodi E, Zanfagnin V, Fava C, Zola P, Ferrero A (2015) Leiomyosarcoma of the Right Iliac Vein Presenting as a Pelvic Mass: A Case Report. Obstet Gynecol Cases Rev 2:040.
Abstracts from 18th International Meeting of the European Society of Gynaecological Oncology (ESGO), October 24-27, 2015 Nice, France
-P.Modaffari, A. Ferrero, L.Fuso, E.Tripodi, G. Menato, F. Giraldi, M.Canis,N Bourdel. Malnutrition among ovarian cancer patients
– L.Fuso, A.Ferrero, E,Tripodi, P. Modaffari, V.Zanfagnin, G. Menato, P. Zola Treatment strategy in advanced ovarian cancer: results from a prospective single institution
– A,Ferrero, L.Fuso, E. Tripodi, A. Daniele, S. Perotto, N. Lanfredini, A. Gadducci >70 years- old ovarian cancer patients: treatment outcome according to modified frailty index (mFI)
2014
-E.PIOVANO, L.FUSO, C.BAIMA POMA, A.FERRERO, S.PEROTTO, E.TRIPODI, E.VOLPI, V.ZANFAGNIN, P.ZOLA Complications after the treatment of endometrial cancer: a prospective study using the French-
italian glossary.. Int J Gynecol Cancer. 2014 Mar;24(3):418-26. doi: 10.1097/IGC. PMID:24463643
2013
Abstracts from 18th International Meeting of the European Society of Gynaecological Oncology (ESGO), 19-22 October 2013, Liverpool, UK
– E.TRIPODI, V.ZANFAGNIN, C.BAIMA POMA, C.FAVA, P.ZOLA, A.FERRERO Leiomyosarcoma of the right iliac vein presenting as a pelvic mass: a case report. Atti congressuali, poster International Journal of Gynecological Cancer, October 2013
2012
-PIOVANO E, PIVETTA E, MODAFFARI P, MARTRA F, BAIMA POMA C, PEROTTO S, TRIPODI E, ZANFAGNIN V, ZOLA P, FERRERO A. A search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasms. Gynecol Obstet Invest. 2012;74(1):21-7. Epub 2012 May 31. Abstract from 14th Biennial Meeting of the International Gynecologic Cancer Society (IGCS) have been published onthe International Journal of Gynecological Cancer, October 2012 -Volume22 -Issue 8
-L. FUSO,E. TRIPODI, V. ZANFAGNIN, S. PEROTTO, P. MODAFFARI, A. FERRERO, P.ZOLA Neoadjuvant chemotherapy in advanced ovarian cancer: results from a single institution experience In: Atti congressuali, poster P 267 International Journal of Gynecological Cancer,October 2012 .
-A. DANIELE, S. PEROTTO, E. TRIPODI,C. VIGNATI, V. ZANFAGNIN, P. MODAFFARI, C. BAIMA POMA, A. FERRERO Clinical trials underepresentation of patients over 70 years with gynecological cancer: an
unsolved discussion. In:Atti congressuali, poster P 138 International Journal of Gynecological Cancer, October 2012.
-V. ZANFAGNIN, E. TRIPODI, C. VIGNATI, S. PEROTTO, A. DANIELE, P. MODAFFARI, A.FERRERO, E. VOLPI.Correlation between preoperative biopsy, frozen section and final histology in type 2 endometrial cancer. In: Atti congressuali, poster P 340 International Journal of Gynecological Cancer,October 2012.
2011
-FERRERO A, DOMPE’ D,RAVARINO N, FUSO L, MAGGIOROTTO F, TRIPODI E, ZOLA P. Angiogenesis and molecular markers in advanced epithelial ovarian cancer: a retrospective study. Gynecol Oncol. 2011 Nov;123(2):301-7. doi: 10.1016/j.ygyno.2011.07.026. Epub 2011 Aug 20. PMID: 21862119
-V.ZANFAGNIN, E.TRIPODI, S.PEROTTO, N.RAVARINO, ZOLA P “Aggressive clinical course of primary invasive vaginal carcinoma associated with HPV type 61: a case report”. La Rivista “Tumori”, Aprile 2011
-ZOLA P. ZANFAGNIN V. TRIPODI E. BAIMA POMA C. “Malattie del Gestotrofoblasto” Dewhurst’s Textbook of Obstetrics and Gynaecology, Cap.28,Edizione 2011
-ESGO Textbook of Gynecological Oncology, Chapter 72, 2011 Edition ZOLA P. , PIOVANO E. PEROTTO S. MODAFFARI P. TRIPODI E.ZANFAGNIN V. Fuso L. Ferrero A. “Classification of complications in gynecological malignancies treatments”
Abstract from 17th INTERNATIONAL MEETING OF THE EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY ESGO,Milan, Italy, September 11-14, 2011” have been published on the International Journal
of Gynecological Cancer, Vol 21, Supplement 3, October 2011
-F. MARTRA, E. TRIPODI, P. MODAFFARI, V. ZANFAGNIN, L. FUSO, G. DE SANSO, P. ZOLA. Ultrasound score versus experienced ultrasound examiner interpretation: are both necessary to improve the management of ovarian masses? In: Atti congressuali, poster P.17th INTERNATIONAL MEETING OF THE EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY ESGO,Milan, Italy, September 11-14, 2011
-F. MARTRA, P. MODAFFARI, E. TRIPODI, V. ZANFAGNIN, E. PIOVANO, E. VOLPI, L. FUSO, P. ZOLA. Could risk factors for spillage in laparoscopy for ovarian cysts be identified? In: Atti congressuali, poster17th INTERNATIONAL MEETING OF THE EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY ESGO,Milan, Italy, September 11-14, 2011
-E. PIOVANO, C. BAIMA POMA, A. FERRERO, L. FUSO, F. MARTRA, P. MODAFFARI, S.PEROTTO, E. TRIPODI, V. ZANFAGNIN, P. ZOLA. Complications of endometrial cancer treatment: a prospective analysis using the french-italian glossaryIn: Atti congressuali, poster17th INTERNATIONAL MEETING OF THE EUROPEAN SOCIETY OF GYNAECOLOGICAL ONCOLOGY ESGO,Milan, Italy, September 11-14, 2011
-L.FUSO, ZANFAGNIN V. E.TRIPODI, C.PAPADAKIS, S.COSIO, R.GIANNICE, T.TOMASELLI, F.CHIUDINELLI, A.BELLICINI, A.GADDUCCI, F.LANDONI, T.MAGGINO, E.SARTORI, P.ZOLA. “Management of non endometrioid (type 2) endometrialcancer: a multicentric retrospective study” 17th International Meeting of the ESGO, 2011, Milan, September 11-14
2010
Abstract from IGCS 13th Biennial Meeting of the International Gynecologic Cancer Society, Prague, October 23-26, 2010” have been published on the International Journal of Gynecological Cancer, Vol 20, Supplement 2, October 2010
-F. MARTRA, P. MODAFFARI, E. PIOVANO, C. BAIMA POMA, E. TRIPODI, V. ZANFAGNIN, E. VOLPI, P. ZOLA Is ultrasound a good exam to evaluate patients with ovarian masses before surgery? In atti congressuali: poster p 1289 13th Biennial Meeting of the International Gynecologic Cancer Society, Prague, October 23-26, 2010
-V. ZANFAGNIN, E.TRIPODI, F. MAROCCO, E.PIOVANO, L. FUSO, A.FERRERO, N. RAVARINO, P.ZOLA. “Pattern of failures and prognostic factors in type 2 endometrial carcinoma: a single institution retrospective
study” 13th Biennal Meeting of the IGCS, 2010, Prague, October 23-26
-S.PEROTTO, E.TRIPODI, V.ZANFAGNIN, N.RAVARINO, L.FUSO, P.ZOLA. A.FERRERO. “Synchronous primary cancers of the endometrium and ovary: a retrospective clinicopathological study”13th Biennal Meeting of the IGCS, 2010, Prague, October 23-26 2009
-P.ZOLA, A.GADDUCCI, T. MAGGINO, E.SARTORI, L.FUSO, E. PIOVANO, S.PEROTTO, C.BAIMA POMA,E.TRIPODI, V.ZANFAGNIN “Il follow-up del carcinoma dell’ovaio: implicazioni di nuovi dati d’efficienza” Atti del Congresso SIGO e AOGOI, Bari, 28- 31 Ottobre 2009
